TROX DEADLINE: ROSEN, INVESTOR RIGHTS COUNSEL, Encourages Tronox Holdings plc Investors with Losses in Excess of $100K to Secure Counsel Before Important November 3 Deadline in Securities Class Action – TROX

TROX DEADLINE: ROSEN, INVESTOR RIGHTS COUNSEL, Encourages Tronox Holdings plc Investors with Losses in Excess of $100K to Secure Counsel Before Important November 3 Deadline in Securities Class Action – TROX GlobeNewswire November 03, 2025 NEW YORK, Nov. 02, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers […]

December 23, 2025 Deadline Approaching: Join Class Action Against James Hardie Industries plc. (JHX) Contact Levi & Korsinsky

NEW YORK, NY / ACCESS Newswire / November 2, 2025 / If you suffered a loss on your James Hardie Industries plc. (NYSE:JHX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/james-hardie-industries-plc-lawsuit-submission-form?prid=175142&wire=1&utm_campaign=30 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com

TLX Investor News: If You Have Suffered Losses in Telix Pharmaceuticals Ltd. (NASDAQ: TLX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

TLX Investor News: If You Have Suffered Losses in Telix Pharmaceuticals Ltd. (NASDAQ: TLX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights GlobeNewswire November 03, 2025 NEW YORK, Nov. 02, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on

Pomerantz LLP Advises Shareholders of Class Action Involving MoonLake Immunotherapeutics – MLTX

NEW YORK CITY, NY / ACCESS Newswire / November 2, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against MoonLake Immunotherapeutics ("Moonlake" or the "Company") (NASDAQ:MLTX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged

Faraday Future Founder and Co-CEO YT Jia Shares Weekly Investor Update: FF Appoints Chris Nixon Cox as Global Strategic Advisor to Accelerate Global Expansion of “EAI + Crypto” Strategy

Faraday Future Founder and Co-CEO YT Jia Shares Weekly Investor Update: FF Appoints Chris Nixon Cox as Global Strategic Advisor to Accelerate Global Expansion of “EAI + Crypto” Strategy GlobeNewswire November 03, 2025 The Company signed with three B2B partners and received non-refundable deposits and non-binding preorders from them totaling more than 200 units of

Blazpay Phase 3 AI Crypto Presale Live: Explosive Gains Await Early Buyers

Blazpay Phase 3 AI Crypto Presale Live: Explosive Gains Await Early Buyers GlobeNewswire November 03, 2025 PANAMA CITY, Nov. 02, 2025 (GLOBE NEWSWIRE) — Phase 3 of the Blazpay AI Crypto Presale is officially LIVE! With 139M BLAZ tokens sold out of 157.3M available, the presale is already over 87% complete, raising $1M in early

November 7, 2025 Deadline Approaching: Join Class Action Against Savara Inc. (SVRA) – Contact Levi & Korsinsky

NEW YORK, NY / ACCESS Newswire / November 2, 2025 / If you suffered a loss on your Savara Inc. (NASDAQ:SVRA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/savara-inc-lawsuit-submission-form?prid=175139&wire=1&utm_campaign=30 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

Benitec Biopharma to Provide Phase 1b/2a Clinical Study Update for BB-301 in Oculopharyngeal Muscular Dystrophy

Benitec Biopharma to Provide Phase 1b/2a Clinical Study Update for BB-301 in Oculopharyngeal Muscular Dystrophy Investor webcast to be held on Monday November 3, 2025 at 8:00 am EST GlobeNewswire November 03, 2025 HAYWARD, Calif., Nov. 02, 2025 (GLOBE NEWSWIRE) — Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or the “Company”), a clinical-stage, gene therapy-focused, biotechnology

HUTCHMED Highlights Pipeline and Business Progress at R&D Updates Event

HUTCHMED Highlights Pipeline and Business Progress at R&D Updates Event GlobeNewswire November 03, 2025 — HUTCHMED unveils its innovative ATTC platform, potentially providing precision oncology with synergistic dual-mechanism of action — — Lead candidate HMPL-A251 harnesses a selective PI3K/PIKK inhibitor payload, demonstrating promising preclinical efficacy and safety — — Progress in global and China trials,

ROSEN, INVESTOR RIGHTS COUNSEL, Encourages WPP plc Investors to Secure Deadline Before Important Deadline in Securities Class Action – WPP

ROSEN, INVESTOR RIGHTS COUNSEL, Encourages WPP plc Investors to Secure Deadline Before Important Deadline in Securities Class Action – WPP GlobeNewswire November 02, 2025 NEW YORK, Nov. 02, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of American Depositary Shares (“ADS” or “ADSs”) of WPP plc (NYSE:

Scroll to Top